Compare FTH & CCXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTH | CCXI |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.0M | 883.4M |
| IPO Year | 2021 | N/A |
| Metric | FTH | CCXI |
|---|---|---|
| Price | $24.48 | $16.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 306.9K | ★ 2.8M |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.50 | $10.09 |
| 52 Week High | $37.90 | $19.69 |
| Indicator | FTH | CCXI |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 61.41 |
| Support Level | $23.82 | $10.13 |
| Resistance Level | $31.61 | $19.69 |
| Average True Range (ATR) | 2.65 | 1.23 |
| MACD | -0.69 | 0.09 |
| Stochastic Oscillator | 16.06 | 86.45 |
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Churchill Capital Corp XI is a blank check company.